Physicians Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$335K Buy
13,923
+4
+0% +$105 0.08% 91
2026
Q1
$391K Buy
13,919
+344
+3% +$9.16K 0.11% 83
2025
Q4
$338K Sell
13,575
-307
-2% -$7.74K 0.09% 90
2025
Q3
$354K Sell
13,882
-1,063
-7% -$26.2K 0.1% 89
2025
Q2
$362K Sell
14,945
-6,682
-31% -$156K 0.11% 89
2025
Q1
$548K Sell
21,627
-7,632
-26% -$200K 0.17% 78
2024
Q4
$776K Sell
29,259
-4,437
-13% -$120K 0.24% 65
2024
Q3
$975K Sell
33,696
-5,293
-14% -$154K 0.3% 60
2024
Q2
$1.09M Sell
38,989
-4,009
-9% -$110K 0.35% 56
2024
Q1
$1.19M Sell
42,998
-1,020
-2% -$28.3K 0.42% 55
2023
Q4
$1.27M Sell
44,018
-6,780
-13% -$205K 0.48% 52
2023
Q3
$1.69M Sell
50,798
-620
-1% -$21.9K 0.69% 37
2023
Q2
$1.89M Sell
51,418
-250
-0.5% -$9.73K 0.74% 35
2023
Q1
$2.11M Buy
51,668
+50
+0.1% +$2.16K 0.89% 33
2022
Q4
$2.65M Sell
51,618
-810
-2% -$38.8K 1.19% 23
2022
Q3
$2.29M Sell
52,428
-929
-2% -$45.1K 1.11% 25
2022
Q2
$2.8M Buy
53,357
+1,079
+2% +$55K 1.25% 23
2022
Q1
$2.71M Sell
52,278
-350
-0.7% -$18.2K 1.03% 31
2021
Q4
$3.11M Buy
52,628
+900
+2% +$44.6K 1.15% 29
2021
Q3
$2.23M Buy
51,728
+10,420
+25% +$462K 0.9% 36
2021
Q2
$1.62M Buy
41,308
+11,465
+38% +$446K 0.66% 46
2021
Q1
$1.08M Buy
29,843
+1,315
+5% +$46.7K 0.46% 57
2020
Q4
$1.05M Sell
28,528
-2,244
-7% -$82.3K 0.51% 56
2020
Q3
$1.07M Buy
30,772
+215
+0.7% +$7.54K 0.53% 51
2020
Q2
$948K Buy
30,557
+3
+0% +$102 0.52% 53
2020
Q1
$946K Buy
30,554
+3,375
+12% +$115K 0.65% 45
2019
Q4
$1.01M Sell
27,179
-389
-1% -$13.9K 0.55% 54
2019
Q3
$940K Sell
27,568
-104
-0.4% -$3.78K 0.54% 53
2019
Q2
$1.14M Sell
27,672
-1,002
-3% -$39.8K 0.67% 44
2019
Q1
$1.16M Buy
28,674
+711
+3% +$28.5K 0.72% 41
2018
Q4
$1.16M Buy
27,963
+8,535
+44% +$354K 0.84% 37
2018
Q3
$813K Sell
19,428
-106
-0.5% -$4.08K 0.56% 56
2018
Q2
$672K Sell
19,534
-843
-4% -$28.8K 0.5% 61
2018
Q1
$682K Sell
20,377
-6,113
-23% -$210K 0.54% 61
2017
Q4
$910K Sell
26,490
-211
-0.8% -$7.2K 0.69% 45
2017
Q3
$904K Sell
26,701
-211
-0.8% -$6.78K 0.74% 45
2017
Q2
$858K Sell
26,912
-1,660
-6% -$52.4K 0.73% 45
2017
Q1
$927K Sell
28,572
-1,129
-4% -$35.6K 0.8% 42
2016
Q4
$1.04M Buy
29,701
+287
+1% +$8.76K 0.85% 39
2016
Q3
$945K Buy
29,414
+952
+3% +$31.8K 0.79% 41
2016
Q2
$951K Buy
28,462
+48
+0.2% +$1.53K 0.83% 38
2016
Q1
$799K Sell
28,414
-295
-1% -$8.43K 0.72% 43
2015
Q4
$879K Buy
+28,709
New +$903K 0.81% 41

Other funds holding PFE

Physicians Financial Services's PFE Position: Q2 2026 in Review

Physicians Financial Services increased its Pfizer (PFE) stake by 0.03% in Q2 2026, buying an estimated $105 and bringing the position to 13,923 shares worth $335K. The position accounts for 0.08% of the portfolio, ranked #91.

Physicians Financial Services first reported a position in PFE in Q4 2015 and has held it in 43 quarters since. The position peaked at $3.11M in Q4 2021. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Physicians Financial Services held 13,923 shares of Pfizer worth $335K as of Q2 2026.
  • Physicians Financial Services bought 4 Pfizer shares in Q2 2026, an estimated $105.
  • Pfizer made up 0.08% of Physicians Financial Services's portfolio in Q2 2026, its #91 holding.
  • Physicians Financial Services first reported a position in Pfizer in Q4 2015 and has held it in 43 quarters since.
  • Physicians Financial Services's Pfizer position peaked at $3.11M in Q4 2021.
  • 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Physicians Financial Services's 13F filing for Q2 2026, filed 21 Jul 2026.